Pennsylvania Report Outlines Path to Help Struggling Pharmacies Combat Closures
A state Insurance Department report offers lawmakers potential solutions as Pennsylvania faces a pharmacy crisis with over 1,000 closures since 2020.
HARRISBURG, PENNSYLVANIA — A new state Insurance Department report released Thursday offers lawmakers potential solutions to address the crisis facing Pennsylvania pharmacies, where more than 1,000 locations have closed since 2020.
The report examines the impact of requiring pharmacy benefit managers to pay pharmacists larger fees for filling prescriptions. These companies, known as PBMs, serve as intermediaries in the pharmaceutical supply chain and have faced criticism from pharmacists who blame them for widespread pharmacy closures.
PBMs Control Prescription Drug Market
Pharmacy benefit managers are hired by insurance plans to manage prescription benefits, negotiating drug costs between insurers and manufacturers while reimbursing pharmacies when patients use insurance coverage. Just three PBMs process roughly 80% of all prescription drug claims in America, with each company part of larger healthcare conglomerates that also own major pharmacy chains and health insurance companies.
Pharmacists argue that PBM reimbursements have declined over time to unsustainable levels, making it difficult to operate profitably. Due to the companies’ market dominance, pharmacy owners say they must accept contract terms or risk losing large numbers of customers.
Widespread Pharmacy Closures Across Commonwealth
The closure rate has reached alarming proportions across Pennsylvania, with more than 1,000 pharmacies shutting down since 2020. This trend has left many communities, particularly rural areas, with reduced access to prescription medications and pharmaceutical services.
Pharmacists have spent years advocating for legislation that would require PBMs to reimburse them based on specific fee structures designed to ensure pharmacy viability. The Insurance Department’s new analysis could provide the foundation for such regulatory changes.
Potential Legislative Solutions Under Review
The report’s findings offer state lawmakers data-driven insights into how adjusted reimbursement requirements might impact both pharmacy operations and overall healthcare costs. The analysis comes as legislators face pressure to address the pharmacy closure crisis that affects medication access for Pennsylvania residents.
The consolidation of the PBM industry has created concerns about market competition and fair pricing practices. With three companies controlling the vast majority of prescription processing, critics argue that independent pharmacies lack negotiating power to secure sustainable reimbursement rates.
Pennsylvania joins other states examining PBM regulation as pharmacy closures continue affecting healthcare access nationwide. The Insurance Department’s report provides specific data that could inform future legislative action to support struggling pharmacy operations while maintaining prescription drug benefit programs.
